Coeptis Therapeutics Holdings Inc at SRAX Sequire Biotechnology Conference (Virtual) Transcript
Hi, everyone. This is Dave Mehalick; I'm the CEO and Co-Founder of Coeptis Therapeutics Holdings, symbol COEP trading on the Nasdaq. Thank you for taking the time today to listen to our presentation.
I'm going to just leave up for a second the cautionary forward-looking statements slide and also the disclaimers. And that will allow us to get into the presentation.
As I said, thanks for taking the time today. The name of the company is Coeptis Therapeutics Holdings, symbol COEP trading on the Nasdaq. We are a Pittsburgh-based biopharmaceutical company focused on cell therapy in the indications of oncology. The company was founded in 2017. I'm one of the three co-founders and also the company's CEO.
I'll just take you through some just some general corporate highlights initially. As I said, the company is a Nasdaq-listed cell therapy company. We recently became Nasdaq listed October 31 of last year. We effected that transaction through a merger with a SPAC called Bull Horn Holdings, and we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
